-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Upgrades Milestone Pharmaceuticals to Buy, Announces $8 Price Target

Benzinga·12/15/2025 16:34:05
Listen to the news
TD Cowen analyst Ritu Baral upgrades Milestone Pharmaceuticals (NASDAQ:MIST) from Hold to Buy and announces $8 price target.